The role of humoral antibody in the rejection of primary renal allografts in sheep

Niels C Pedersen, B. Morris

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 hr of the graft being finally rejected. Appearance of the antibody in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them, were similar to those seen in the terminal stages of primary rejection. These findings led to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.

Original languageEnglish (US)
Pages (from-to)619-630
Number of pages12
JournalJournal of Experimental Medicine
Volume140
Issue number3
StatePublished - 1974

Fingerprint

Allografts
Sheep
Kidney
Antibodies
Transplants
Lymph
Serum Globulins
Capillary Permeability
Cell Count
Lymphocytes
Antigens
Serum
Proteins

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The role of humoral antibody in the rejection of primary renal allografts in sheep. / Pedersen, Niels C; Morris, B.

In: Journal of Experimental Medicine, Vol. 140, No. 3, 1974, p. 619-630.

Research output: Contribution to journalArticle

@article{0bc5423d91014dbcbed61ad787b86a66,
title = "The role of humoral antibody in the rejection of primary renal allografts in sheep",
abstract = "Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 hr of the graft being finally rejected. Appearance of the antibody in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them, were similar to those seen in the terminal stages of primary rejection. These findings led to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.",
author = "Pedersen, {Niels C} and B. Morris",
year = "1974",
language = "English (US)",
volume = "140",
pages = "619--630",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "3",

}

TY - JOUR

T1 - The role of humoral antibody in the rejection of primary renal allografts in sheep

AU - Pedersen, Niels C

AU - Morris, B.

PY - 1974

Y1 - 1974

N2 - Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 hr of the graft being finally rejected. Appearance of the antibody in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them, were similar to those seen in the terminal stages of primary rejection. These findings led to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.

AB - Antibody which had cytotoxic and agglutinating activity against donor lymphocytes appeared in the blood stream of primary renal allograft recipients usually within 48 hr of the graft being finally rejected. Appearance of the antibody in the blood was associated with severe alterations in vascular permeability and this led to increases in the numbers of red cells and in the protein content of the lymph coming from the allograft. It was possible to elute cytotoxic and agglutinating antibody from renal allograft tissue, showing that this type of antibody was bound to graft antigens during the rejection process. The transfusion of whole serum or serum globulins obtained from sheep that had previously rejected allografts led to the destruction of recently installed renal grafts and the histological changes produced in these grafts and the alterations in the composition of the lymph coming from them, were similar to those seen in the terminal stages of primary rejection. These findings led to the conclusion that in the sheep, at least the terminal stage of primary renal allograft rejection is mediated by humoral antibody.

UR - http://www.scopus.com/inward/record.url?scp=0016268604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016268604&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 619

EP - 630

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 3

ER -